PLEASANTON, Calif., Feb. 01, 2017 (GLOBE NEWSWIRE) -- ZELTIQ® (Nasdaq:ZLTQ), a medical technology company
focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today
announced that Mark Foley, President and Chief Executive Officer, and Taylor Harris, Senior Vice President and Chief Financial
Officer, are scheduled to present at Leerink Partners 6th Annual Global Healthcare Conference in New York, NY. The
Leerink Conference will utilize a fireside chat format for the presentation.
| |
|
Event: |
Leerink Partners 6th Annual Global Healthcare
Conference |
| |
|
Date: |
Thursday, February 16, 2017 |
| |
|
Time: |
11:30 am ET |
| |
|
|
|
Audio webcast of the Company’s presentation will be available by visiting the investor relations section of
ZELTIQ’s web site at www.coolsculpting.com. A replay of the presentation will be available for 90 days.
About ZELTIQ® Aesthetics
ZELTIQ is a medical technology company focused on developing and commercializing products utilizing its proprietary
controlled-cooling technology platform. ZELTIQ’s first commercial product, the CoolSculpting® System, is designed to selectively
reduce stubborn fat bulges. CoolSculpting is based on the scientific principle that fat cells are more sensitive to cold than the
overlying skin and surrounding tissues. It utilizes patented technology of precisely controlled cooling to reduce the temperature
of fat cells in the treated area, which is intended to cause fat cell elimination through a natural biological process known as
apoptosis. ZELTIQ developed CoolSculpting to safely, noticeably, and measurably reduce the fat layer.
MEDIA CONTACT: Jill Knepper Ketchum for ZELTIQ 310-437-2517 INVESTOR RELATIONS: Taylor Harris ZELTIQ, Senior Vice President and CFO 925-474-2500 Nick Laudico The Ruth Group for ZELTIQ 646-536-7030
